All Type of News
Korea's pharmaceutical industry losing competitive edge
Korea's pharmaceutical industry is faced with serious problems with falling competitiveness, and the government needs to employ a series of measures to boost its ability to compete in the global market, indu...
Drug packages to show appropriate descriptions for consumers.
The KFDA plans to improve descriptions for all drug packages in order to provide better drug informations for consumers and to prevent drug abuse and misuse.
In the OTC drug study workshop on June 12 led by Prof. ...
MOHW's more substantiated NHI development plans.
The MOHW presented the mid and long term development plans on June 17 for the national health insurance to the National Assembly Standing Committee through the NHI development panels (hereinafter called Panel).
Wit...
Local pharmaceutical firms eager to find more foreigner partners
Pharmaceutical sources say that more and more pharmaceutical firms are scurrying to seek their foreign partners in the United States, Europe and Japan, as a way to expand their presence in the domestic ethicals market...
Senior researchers shun domestic pharmaceutical industry
Pharmaceutical business sources say that the increasing exodus trend of senior researchers working in domestic pharmaceutical firms will put a wet blanket on the long-term development of the industry.
This unfavora...
GSK to introduce Infanrix DTPa vaccine in Korea
GlaxoSmithKline Korea said that Infanrix DTPa vaccine, which has been widely used all over the world, will be launched in domestic market from June 23 after fulfilling necessary procedures such as state-run tests and ...
Zuellig's drug wholesale business stepping in China.
Zuellig Pharma China succeeded in establishing a joint venture drug wholesale company named "Zuellig Xinxing Pharmaceutical in China at the early of June after obtaining its approval from the Ministry of Commerce.
...
KFDA okayed Iressa sales in Korea.
The KFDA approved Iressa, a non-small lung cancer drug developed by Astra Zeneca on June 14 after clearing the comparative dissolution test problems.
The registration in Korea will be the 6th after Japan, America, ...
Medium-sized pharmaceutical firms turn eyes to new products launching
In a desperate attempt to spark some life into the depressed domestic pharmaceutical market, major medium-sized pharmaceutical firms are launching a variety of their new products to prop up their market shares in para...
Domestic OTC wholesalers struggling with Zuellig Korea with a sense of crisis
With mounting concerns over increasing portion of products handled by Zuellig Korea exceeding 20 percent (more than 30 percent in some cases) per wholesaler, both domestic OTC and ethical wholesalers are in a dilemma ...
